Guided Imagery of the Gynecological Cancer

The goal of this randomized controlled trial is to evaluate the effectiveness of a guided imagery intervention in women receiving chemotherapy for gynecological cancers at Başkent University Ankara Hospital Outpatient Chemotherapy Unit. Does guided imagery improve psychological or physical outcomes during chemotherapy? How do outcomes differ between the intervention (guided imagery) and control (standard information) groups? Researchers will compare both groups to assess the effect of guided imagery across three repeated measurements. Participants will: Be randomly assigned (1:1) to intervention or control groups via an online randomization tool. Complete outcome assessments at three time points. Be part of a minimum sample of 48 women (24 participants per group), based on the power analysis. The study will follow the CONSORT-Outcomes 2022 guideline and be registered at ClinicalTrials.gov.

Inclusion Criteria: * Having a diagnosis of another type of cancer * An ECOG (Eastern Cooperative Oncology Group) performance score of ≥3 (PS 3: Confined to bed for more than half of the day, limited self-care; PS 4: Completely bedridden, unable to perform self-care) Exclusion Criteria: * Choosing to withdraw from the study * Refusing to practice guided imagery before chemotherapy treatment